SII plans plant in Africa
Africa was the only continent that did not have its own manufacturing capacity for COVID shots during the worst phases of the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Serum Institute of India
Johns Hopkins Bloomberg School of Public Health honours Dr Cyrus S Poonawalla
Dr Poonawalla has been felicitated with Dean’s medal for his life-long contribution with this honour, reserved for luminaries…
SII seeks government nod to manufacture and stockpile qHPV vaccine against cervical cancer
The firm will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI)…
SII and Symbiosis International University sign MoU to set up research centre for vaccine and…
The MoU will see both the entities work towards promoting research and innovation to increase impact of vaccines, technologies and…
SII lowers price of each dose of Covovax jab from Rs 900 to Rs 225
The firm is reducing the price of each dose from Rs 900 to Rs 225 plus Goods and Services Tax (GST) for private hospitals. In…
Biocon Q4FY22 revenue at Rs 2,476 crores, up 21 per cent
FY22 revenue at Rs 8,397 crores, up 14 per cent; core EBITDA up 18 per cent at Rs 2,669 crores; PBT (before Exceptional Item) at…
NTAGI panel recommends Covovax in vaccination drive for 12-17 years’ age group
India's drug regulator had approved Covovax for restricted use in emergency situations in adults on 28th December last year and in…
SII urges Centre to use 10 crore Covishield doses free of cost amid rising cases
The firm has written to the Ministry of Health and Family Welfare (MoH&FW) that if these 10 crore free doses of Covishield are…
SII asks govt to reduce time gap for Covishield booster dose to six months
Adar Poonawalla, CEO, SII also pitched for a global pact for vaccine utilisation
DCGI gives EUA nod to SII’s Covovax for 12-17 years’ age group
It is the fourth vaccine to receive the regulator's nod for use among those below 18 years